Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR.

Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR. Todd Plott, M.D., Chief Medical Officer, Epiphany Dermatology will join Robert ...

Establishing an innovative class of polyomavirus antivirals spanning BK and JC virus indications CANTON, Mass.--(BUSINESS ...

A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

Mayo Clinic scientists are exploring an unusual but promising strategy to treat one of the deadliest bile duct cancers by turning milk into a microscopic delivery system for gene therapy. Their work ...

First-line treatment for advanced urothelial carcinoma has evolved in recent years from traditional chemotherapy to targeted immunotherapy drugs enfortumab vedotin (Padcev) and pembrolizumab (Keytruda ...

The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

Keytruda drug is approved for a wide range of solid tumors and blood cancers, often for cases that are advanced, metastatic ...

The experimental therapy is designed to activate the immune system's ability to not only recognize and destroy cancer cells, ...